The FDA is expected to decide on treatments for COPD, psoriasis, rare neuroendocrine tumors, and a next-generation COVID-19 vaccine.

Rutgers Health researchers have developed an oral antiviral drug candidate for COVID-19 that could overcome major limitations of Paxlovid, currently the most prescribed oral treatment.

Five years after the COVID-19 pandemic, funding for Ralph Baric's lab, which developed the first COVID treatment, is up in ...

Researchers found a protein that's essential for an enterovirus to enter human cells. Although not the infamous example—that ...